The 2'5'-oligoadenylat synthetase activity increase in interferon treated malignant kidney and bladder cells

Authors

  • A. A. Verkhatskaya Institute of Molecular Biology and Genetics, NAS of Ukraine 150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680 Author
  • O. L. Prokhnevskaya Institute of Molecular Biology and Genetics, NAS of Ukraine 150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680 Author
  • M. P. Zavelevich Institute of Molecular Biology and Genetics, NAS of Ukraine 150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680 Author
  • G. Kh. Matsuka Institute of Molecular Biology and Genetics, NAS of Ukraine 150, Akademika Zabolotnoho Str., Kyiv, Ukraine, 03680 Author

DOI:

https://doi.org/10.7124/bc.000308

Abstract

The article deals with the investigation aimed to use the 2'5'oligoadenylate synthetase activity as the marker of interferon-sensitivity of some cells.

References

Strander H. Interferon treatment of human neoplasia. Adv Cancer Res. 1986;46:1-265.

Balkwill FR, Griffin DB, Lee AE. Interferons alpha and gamma differ in their ability to cause tumour stasis and regression in vivo. Eur J Cancer Clin Oncol. 1989;25(10):1481-6.

Farrell PJ, Sen GC, Dubois MF, Ratner L, Slattery E, Lengyel P. Interferon action: two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proc Natl Acad Sci U S A. 1978;75(12):5893-7.

Kortsaris A. 2', 5' oligo (A) synthetase levels in interferon-sensitive or resistant breast cancer cells. Microbiologica. 1988;11(2):111-7.

Chao TY, Chu TM. Effect of indomethacin on tumor-infiltrating lymphocytes of a spontaneously developed murine mammary adenocarcinoma. Cancer Immunol Immunother. 1989;30(3):158-64.

Minks MA, Benvin S, Maroney PA, Baglioni C. Synthesis of 2'5'-oligo(A) in extracts of interferon-treated HeLa cells. J Biol Chem. 1979;254(12):5058-64.

Hovanessian AG, Laurent AG, Chebath J, Galabru J, Robert N, Svab J. Identification of 69-kd and 100-kd forms of 2-5A synthetase in interferon-treated human cells by specific monoclonal antibodies. EMBO J. 1987;6(5):1273-80.

Barouki FM, Witter FR, Griffin DE, Nadler PI, Woods A, Wood DL, Lietman PS. Time course of interferon levels, antiviral state, 2',5'-oligoadenylate synthetase and side effects in healthy men. J Interferon Res. 1987;7(1):29-39.

Ostlund L, Einhorn S, Robèrt KH. Induction of 2',5'-oligoadenylate synthetase and blast transformation in primary chronic lymphocytic leukemia cells following exposure to interferon in vitro. Cancer Res. 1986;46(4 Pt 2):2160-3.

Ostlund L, Grandér D, Juliusson G, Robèrt KH, Lundgren E, Einhorn S. Alpha-interferon receptors in malignant B-cells from patients with chronic lymphocytic leukemia: relation to induction of 2'-5'-oligoadenylate synthetase and blast transformation. Cancer Res. 1989;49(12):3425-30.

Porzsolt F, Digel W, Jacobsen H, Mittnacht S, Kirchner H, Heimpel H. Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer. Cancer. 1988;61(2):288-93.

Published

1991-11-20

Issue

Section

Short Communications